Loading company…
Strongbridge Biopharma is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Strongbridge Biopharma plc develops and markets biopharmaceutical products for rare diseases, including treatments for Cushing's disease and other rare endocrine disorders. Founded in 1996 in the United States, the company is listed as Public, with its headquarters given as Dublin, Ireland. A Private Placement in September 2020 sold 11.11 million shares at USD 2.25 per share, and the company reported 2020 revenue of USD 30.73 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in